These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6202980)

  • 21. Pharmacology of LY195115, a potent, orally active cardiotonic with a long duration of action.
    Hayes JS; Pollock GD; Wilson H; Bowling N; Robertson DW
    J Cardiovasc Pharmacol; 1987 Apr; 9(4):425-34. PubMed ID: 2438505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concentration-response curves of positive inotropic agents before and after ouabain pretreatment.
    Brown L; Erdmann E
    Cardiovasc Res; 1985 May; 19(5):288-98. PubMed ID: 3995524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dose-response following single administrations of a new cardiac performance enhancer RO 13-6438 in normal volunteers.
    Belz GG; Stern HC; Butzer R
    J Cardiovasc Pharmacol; 1985; 7(1):86-90. PubMed ID: 2580156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systemic and coronary hemodynamic actions and left ventricular functional effects of levosimendan in conscious dogs.
    Harkin CP; Pagel PS; Tessmer JP; Warltier DC
    J Cardiovasc Pharmacol; 1995 Aug; 26(2):179-88. PubMed ID: 7475041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological studies with the alpha 2-adrenoceptor antagonist midaglizole. Part I: Respiratory and cardiovascular systems.
    Hirohashi M; Takasuna K; Yamashita N; Tamura K
    Arzneimittelforschung; 1991 Jan; 41(1):9-18. PubMed ID: 1675573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular properties of a new cardiotonic agent: MDL 17,043 (1.3-dihydro-4-methyl-5-[4-(methylthio)-benzoyl]-2H-imidazol-2-one).
    Dage RC; Roebel LE; Hsieh CP; Weiner DL; Woodward JK
    J Cardiovasc Pharmacol; 1982; 4(3):500-8. PubMed ID: 6177949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular effects and plasma levels of denopamine (TA-064), a new positive inotropic agent, in chronically instrumented dogs.
    Ikeo T; Nagao T; Suzuki T; Yabana H; Nakajima H
    Jpn J Pharmacol; 1985 Oct; 39(2):191-9. PubMed ID: 4087566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The positive inotropic and chronotropic effects of evodiamine and rutaecarpine, indoloquinazoline alkaloids isolated from the fruits of Evodia rutaecarpa, on the guinea-pig isolated right atria: possible involvement of vanilloid receptors.
    Kobayashi Y; Hoshikuma K; Nakano Y; Yokoo Y; Kamiya T
    Planta Med; 2001 Apr; 67(3):244-8. PubMed ID: 11345696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological profile of LAS 31180, a new inotropic/vasodilator quinolone derivative.
    Gras J; Cardelús I; Beleta J; Gristwood RW; Palacios JM; Llenas J
    Arzneimittelforschung; 2000 Nov; 50(11):980-6. PubMed ID: 11148864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemodynamic profile of the cardiotonic agent pimobendan.
    van Meel JC; Diederen W
    J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S1-6. PubMed ID: 2478784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo evidence of positive inotropism of EMD 57033 through calcium sensitization.
    Haeusler G; Jonas R; Minck KO; Schliep HJ; Schelling P; Weygandt H; Lues I
    J Cardiovasc Pharmacol; 1997 May; 29(5):647-55. PubMed ID: 9213208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct negative inotropic and lusitropic effects of sevoflurane.
    Harkin CP; Pagel PS; Kersten JR; Hettrick DA; Warltier DC
    Anesthesiology; 1994 Jul; 81(1):156-67. PubMed ID: 8042785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of oxyphenamone, a new inodilator, on cardiac hemodynamics in normal rat, cat and dog].
    Fan LL; Sun LH; Li J
    Yao Xue Xue Bao; 1997 Oct; 32(10):744-9. PubMed ID: 11596216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of left ventricular end-systolic pressure-volume relations with an impedance catheter and transient inferior vena cava occlusion: use of this system in the evaluation of the cardiotonic effects of dobutamine, milrinone, Posicor and epinephrine.
    McKay RG; Miller MJ; Ferguson JJ; Momomura S; Sahagian P; Grossman W; Pasternak RC
    J Am Coll Cardiol; 1986 Nov; 8(5):1152-60. PubMed ID: 3760389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coronary vasodilation and positive inotropic effect of non steroidal cardiotonics.
    Decker N; Grima M; Schwartz J
    J Pharmacol; 1985; 16(4):391-402. PubMed ID: 4094436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular actions of OPC-18790: a novel positive inotropic agent with little chronotropic action.
    Hosokawa T; Mori T; Fujiki H; Kinoshita S; Takemoto K; Imaizumi T; Noda T; Ohura M; Tominaga M; Yabuuchi Y
    Heart Vessels; 1992; 7(2):66-75. PubMed ID: 1328145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Compared peripheral vascular responses to intravenous and intra-arterial administrations of positive inotropic agents in conscious dogs.
    Gosgnach M; Gérard JL; Berdeaux A; Giudicelli JF
    Fundam Clin Pharmacol; 1991; 5(8):709-18. PubMed ID: 1783360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ICI D7288, a novel sinoatrial node modulator.
    Marshall PW; Rouse W; Briggs I; Hargreaves RB; Mills SD; McLoughlin BJ
    J Cardiovasc Pharmacol; 1993 Jun; 21(6):902-6. PubMed ID: 7687714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of some new positive inotropic agents in guinea pigs.
    van Meel JC
    Pharmacology; 1985; 31(1):1-10. PubMed ID: 3161096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular pharmacology of 6-[4-(4'-pyridyl)aminophenyl]-4,5-dihydro-3(2H)-pyridazinone hydrochloride, a novel and potent cardiotonic agent with vasodilator properties.
    Narimatsu A; Kitada Y; Satoh N; Suzuki R; Okushima H
    Arzneimittelforschung; 1987 Apr; 37(4):398-406. PubMed ID: 3606694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.